|Publication Year||December, 2019|
The value of the domestic production of medicines increased by an average annual rate of 10.7% during the period 2002-2011 while in 2012 it registered a fall of 9.2%. However, the Greek pharmaceutical industry "quickly adapted" to the new conditions of the domestic market (increasing demand for generic medicines, exports, etc.). As a result since 2013 the total value of domestically produced medicines has been increasing.
The overall size of the assessed market increased during the period 2000-2009, by an average annual growth rate of 14.1%. However, the difficult course of the Greek economy in recent years and the successive reductions in drug prices have resulted in a decline in market value from 2010 onwards. However, from 2016 onwards it has been increasing, as a result of the ever-increasing hospital pharmaceutical expenditure and in 2018 it registered a rise of 8.8%.
Approximately 43.2% of the total sales of medicines (in value) regards sales to hospitals.